Intracellular activation of 4-hydroxycyclophosphamide into a DNA-alkylating agent in human leucocytes
- 8 September 2021
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 51 (10) , 1188-1198
Abstract
The conversion of the cyclophosphamide intermediate metabolite 4-hydroxycyclophosphamide (4-OHCP) to the final cytotoxic metabolite phosphoramide mustard (PAM) is classically assumed to occur via chemical hydrolysis of the phospho-ester bond. Whilst it has been suggested previously that this reaction could be enzyme-catalysed, there was only indirect evidence for this (i.e. formation of the by-product acrolein). Using an assay to detect formation of DNA-alkylating adducts which block PCR amplification (QPCR-block assay), we have demonstrated that 4-OHCP can be activated by peripheral blood mononuclear cells (PBMC). The DNA-alkylating potency of 4-OHCP in PBMC increased >18-fold compared to the intrinsic reactivity of 4-OHCP for purified gDNA. We also found that immortalised T-cells (Jurkat) had a similar ability to activate 4-OHCP into a DNA alkylating agent, whereas there was no appreciable activation in epithelial derived (Caco-2) cells. This suggests the possibility of tissue-specific enzyme expression. Of the candidate enzymes tested only recombinant human cAMP-phosphodiesterase-PDE4B and snake-venom phosphodiesterase (PDE-I) could catalyse this activation into a DNA-alkylating agent. This enzymatic catalysis of the phospho-ester bond (P-O-C) is a hitherto unrecognised feature of this important immunomodulatory drug and should be investigated further.Keywords
This publication has 43 references indexed in Scilit:
- Cyclophosphamide inhibits the generation and function of CD8+ regulatory T cellsHuman Immunology, 2012
- Acrolein induced DNA damage, mutagenicity and effect on DNA repairMolecular Nutrition & Food Research, 2011
- Cyclophosphamide and cancer: golden anniversaryNature Reviews Clinical Oncology, 2009
- Rolipram, a specific type‐4 phosphodiesterase inhibitor, inhibits cyclophosphamide‐induced haemorrhagic cystitis in ratsBJU International, 2008
- Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamideBlood, 2005
- Identification of phosphoramide mustard/DNA adducts using tandem mass spectrometryRapid Communications in Mass Spectrometry, 1990
- The mechanism of activation of 4-hydroxycyclophosphamideJournal of Medicinal Chemistry, 1987
- Activated cyclophosphamide: An enzyme-mechanism-based suicide inactivator of DNA polymerase/3??5? exonucleaseJournal of Cancer Research and Clinical Oncology, 1984
- Toxicity, interstrand cross-links and DNA fragmentation induced by ‘activated’ cyclophosphamide in yeast: Comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustardChemico-Biological Interactions, 1982
- Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metaboliteJournal of Mass Spectrometry, 1975